Work

Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease

Year: 2017

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Pediatric Nephrology

DOI: 10.1007/s00467-017-3787-0

Authors: Sahar Fathallah-Shaykh, Dorota Drozdz, Joseph Flynn, Randall Jenkins, Katherine Wesseling-Perry, Sarah J. Swartz, Craig Wong, Beverly Accomando, Gerald F. Cox, Bradley A. Warady

Institutions: University of Alabama at Birmingham, Jagiellonian University, Seattle Children's Hospital, Oregon Health & Science University, University of California, Los Angeles, Baylor College of Medicine, Texas Children's Hospital, University of New Mexico Health Sciences Center, Editas Medicine (United States), Children's Mercy Hospital

Language: English

Topic: Parathyroid Disorders and Treatments

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Amgen, Sanofi, Arbor Pharmaceuticals, Genentech

OpenAlex ID: W2756111007

FWCI: 1.467

Cites: 37

Cited by: 14

Related to: 10